IL117907A0 - Truncated IGF-I - Google Patents

Truncated IGF-I

Info

Publication number
IL117907A0
IL117907A0 IL11790796A IL11790796A IL117907A0 IL 117907 A0 IL117907 A0 IL 117907A0 IL 11790796 A IL11790796 A IL 11790796A IL 11790796 A IL11790796 A IL 11790796A IL 117907 A0 IL117907 A0 IL 117907A0
Authority
IL
Israel
Prior art keywords
truncated igf
igf
truncated
Prior art date
Application number
IL11790796A
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of IL117907A0 publication Critical patent/IL117907A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL11790796A 1995-04-21 1996-05-14 Truncated IGF-I IL117907A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501472A SE9501472D0 (en) 1995-04-21 1995-04-21 Truncated IGF-I

Publications (1)

Publication Number Publication Date
IL117907A0 true IL117907A0 (en) 1996-08-04

Family

ID=20398031

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11790796A IL117907A0 (en) 1995-04-21 1996-05-14 Truncated IGF-I

Country Status (4)

Country Link
AU (1) AU5412996A (en)
IL (1) IL117907A0 (en)
SE (1) SE9501472D0 (en)
WO (1) WO1996033216A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
SE9802938D0 (en) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
AU762047B2 (en) 1999-01-06 2003-06-19 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
ATE284415T1 (en) 1999-01-06 2004-12-15 Genentech Inc MUTATED VARIANT OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I)
CA2376284A1 (en) * 1999-06-21 2000-12-28 Murdoch Childrens Research Institute A method for the prophylaxis and/or treatment of medical disorders
DK1282437T3 (en) 2000-05-16 2008-06-30 Genentech Inc Treatment of cartilage disorders
EP1358209B1 (en) 2001-02-09 2006-12-27 Genentech, Inc. Crystallization of igf-1
CA2439735A1 (en) 2001-03-14 2002-09-19 Genentech, Inc. Igf antagonist peptides
CN102861321A (en) 2003-09-12 2013-01-09 特西卡股份有限公司 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency
WO2021005604A1 (en) 2019-07-11 2021-01-14 Opko Biologics Ltd. Long-acting igf-1 or igf-1 variants and methods of producing same
GB201913196D0 (en) 2019-09-12 2019-10-30 Univ Newcastle Culture method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
NZ255461A (en) * 1992-08-20 1996-12-20 Biotechnology & Biolog Science Specific binding molecules for insulin-like-growth-factor-1 (igf-1), antigens capable of generating them and their use in enhancing igf-1 activity
SE9402332D0 (en) * 1994-07-01 1994-07-01 Pharmacia Ab IGF-1

Also Published As

Publication number Publication date
WO1996033216A1 (en) 1996-10-24
SE9501472D0 (en) 1995-04-21
AU5412996A (en) 1996-11-07

Similar Documents

Publication Publication Date Title
DE69513693D1 (en) Positions-servo-system
DE59607964D1 (en) Oxymethoxy-3-aryl-pyron-derivate
DE59607241D1 (en) Endotracheal-tubus
IL117907A0 (en) Truncated IGF-I
DE59610991D1 (en) Cyclopeptidderivate
DE59608164D1 (en) Cyclohexenonoximether-metallsalze
DE59605001D1 (en) Luftreinigungsgerät
DE59602888D1 (en) Breitstreckaggregat
DE59602030D1 (en) Zellige polyurethan-elastomere
DE59602283D1 (en) Inchbremseinrichtung
GB9526613D0 (en) Sequence
DE59505396D1 (en) Handhobelmaschine
GB9514766D0 (en) Twistlocks
AP9600802A0 (en) Libricant
DE59600830D1 (en) Breitstrahldüse
DE59604506D1 (en) Rückkühlsystem
DE59604913D1 (en) Carbonylverbindungen
CA76097S (en) Can
DE59609059D1 (en) Conventional-direct-glazing
AU1105P (en) DALESE Metrosideros excelsus
ZA961668B (en) Constructional elements
GB9616825D0 (en) Strawcrete (cellucretes)
GB9517968D0 (en) Finger-guard (web-plate)
GB9517905D0 (en) Improved can
AU125853S (en) Tea - towel